GBP2 promotes M1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy

por Li, Xiaohui, Liu, Jialu, Zeng, Mengru, Yang, Kexin, Zhang, Shumin, Liu, Yifei, Yin, Xiangxiang, Zhao, Chanyue, Wang, Wenpeng, Xiao, Li
Publicado 2023

Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease

por Yang, Jinfei, Li, Chenrui, Liu, Yan, Han, Yachun, Zhao, Hao, Luo, Shilu, Zhao, Chanyue, Jiang, Na, Yang, Ming, Sun, Lin
Publicado 2022

DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy

por Yang, Ming, Luo, Shilu, Jiang, Na, Wang, Xi, Han, Yachun, Zhao, Hao, Xiong, Xiaofen, Liu, Yan, Zhao, Chanyue, Zhu, Xuejing, Sun, Lin
Publicado 2021

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease

por Luo, Shilu, Yang, Ming, Zhao, Hao, Han, Yachun, Jiang, Na, Yang, Jinfei, Chen, Wei, Li, Chenrui, Liu, Yan, Zhao, Chanyue, Sun, Lin
Publicado 2021

PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease

por Zhao, Chanyue, Li, Li, Li, Chenrui, Tang, Chengyuan, Cai, Juan, Liu, Yu, Yang, Jinfei, Xi, Yiyun, Yang, Ming, Jiang, Na, Han, Yachun, Liu, Yan, Luo, Shilu, Xiao, Li, Sun, Lin
Publicado 2022

PACS-2 deficiency aggravates tubular injury in diabetic kidney disease by inhibiting ER-phagy

por Yang, Jinfei, Li, Li, Li, Chenrui, Chen, Wei, Liu, Yan, Luo, Shilu, Zhao, Chanyue, Han, Yachun, Yang, Ming, Zhao, Hao, Jiang, Na, Xi, Yiyun, Tang, Chengyuan, Cai, Juan, Xiao, Li, Liu, Huafeng, Sun, Lin
Publicado 2023